Lv1
32 积分 2023-04-21 加入
A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies
24天前
已完结
CD28 co-stimulation: novel insights and applications in cancer immunotherapy
1个月前
已完结
Rational design of anti-GITR-based combination immunotherapy
1个月前
已完结
Bispecific Anti-OX40/5T4 Antibodies for Cancer Treatment
1个月前
已关闭
4-1BB and OX40 Dual Costimulation Synergistically Stimulate Primary Specific CD8 T Cells for Robust Effector Function
1个月前
已完结
First-in-human, phase 1 dose escalation study of SL-279252, a hexameric PD1-Fc-OX40L fusion protein, in patients with advanced solid tumors and lymphoma
1个月前
已完结
BOXR1030, an anti-GPC3 CAR with exogenous GOT2 expression, shows enhanced T cell metabolism and improved anti-cell line derived tumor xenograft activity
1个月前
已完结
Facilitating Selection with Artificial Intelligence-Based Glypican-3 Expression Quantification in Patients with Solid Tumors
1个月前
已完结
Facilitating Selection with Artificial Intelligence-Based Glypican-3 Expression Quantification in Patients with Solid Tumors
1个月前
已完结
皖公网安备34019202002308
